Health Care [ 3/12 ] | Biotechnology [ 26/74 ]
NASDAQ | Common Stock
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases.
Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine for the prevention of invasive pneumococcal disease.
The company also develops VAX-31 to protect against emerging strains and to help address antibiotic resistance; VAX-A1, a novel conjugate vaccine candidate to prevent disease caused by Group A Streptococcus; VAX-PG, a novel protein vaccine candidate targeting keystone pathogen responsible for periodontitis; and VAX-GI to prevent Shigella, a bacterial illness.
The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020.
Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Nov 4, 24 | -0.83 Increased by +8.79% | -1.13 Increased by +26.55% |
| Aug 6, 24 | -1.10 Decreased by -57.14% | -0.98 Decreased by -12.24% |
| May 8, 24 | -0.85 Decreased by -21.43% | -1.17 Increased by +27.35% |
| Feb 27, 24 | -1.82 Decreased by -78.43% | -1.07 Decreased by -70.09% |
| Nov 6, 23 | -0.91 Increased by +2.15% | -0.84 Decreased by -8.33% |
| Aug 8, 23 | -0.70 Increased by +12.50% | -0.74 Increased by +5.41% |
| May 8, 23 | -0.70 Decreased by -2.94% | -0.83 Increased by +15.66% |
| Feb 27, 23 | -1.02 Decreased by -85.45% | -0.93 Decreased by -9.68% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 24 | N/A Decreased by N/A% | -103.12 M Decreased by -11.29% | - - |
| Jun 30, 24 | 0.00 Decreased by N/A% | -128.70 M Decreased by -88.33% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 24 | 0.00 Decreased by N/A% | -95.02 M Decreased by -96.48% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 23 | 14.45 M Increased by +N/A% | -180.80 M Decreased by -93.48% | Decreased by -1.25 K% Decreased by N/A% |
| Sep 30, 23 | 0.00 Decreased by N/A% | -92.66 M Decreased by -61.84% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 23 | 0.00 Decreased by N/A% | -68.34 M Decreased by -38.96% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 23 | 0.00 Decreased by N/A% | -48.36 M Decreased by -24.80% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 22 | 0.00 Decreased by N/A% | -93.45 M Decreased by -227.16% | Decreased by N/A% Decreased by N/A% |